Prognostic Value of the Tumour-Infiltrating Dendritic Cells in Colorectal Cancer: A Systematic Review

REFERENCES

• Al-Hassi HO, Mann ER, Sanchez B, English NR, Peake STC, Landy J, Man R, Urdaci M, Hart AL, Fernandez-Salazar L, Lee GH, Garrote JA, Arranz E, Margolles A, Stagg AJ, Knight SC, Bernardo D (2014). Altered human gut dendritic cell properties in ulcerative colitis are reversed by Lactobacillus plantarum extracellular encrypted peptide STp. Mol Nutr Food Res. 58:1132–1143. doi:10.1002/mnfr.201300596
   PubMed Web of Science ®Google Scholar
• Ambe K, Mori M, Enjoji M (1989). S-100 protein-positive dendritic cells in colorectal adenocarcinomas. Distribution and relation to the clinical prognosis. Cancer. 63, 496–503.
   PubMed Web of Science ®Google Scholar
• Banchereau J, Briere F, Caux C, Davoust J, Lebecque S, Liu YJ, Pulendran B, Palucka K (2000). Immunobiology of dendritic cells. Annu Rev Immunol. 18:767–811. doi:10.1146/annurev.immunol.18.1.767
   PubMed Web of Science ®Google Scholar
• Conti J, Thomas G (2011). The role of tumour stroma in colorectal cancer invasion and metastasis. Cancers. 3:2160–2168. doi:10.3390/cancers3022160
   PubMedGoogle Scholar
• Cui G, Yuan A, Goll R, Olsen T, Husebekk A, Vonen B, Florholmen J (2007). Distinct changes of dendritic cell number and IL-12 mRNA level in adjacent mucosa throughout the colorectal adenoma-carcinoma sequence. Cancer Immunol Immunother. 56:1993–2001. doi:10.1007/s00262-007-0345-9
   PubMed Web of Science ®Google Scholar
• Dadabayev AR, Sandel MH, Menon AG, Morreau H, Melief CJM, Offringa R, van der Burg SH, Janssen-van Rhijn C, Ensink NG, Tollenaar RA, van de Velde CJ, Kuppen PJK (2004). Dendritic cells in colorectal cancer correlate with other tumor-infiltrating immune cells. Cancer Immunol Immunother. 53:978–986. doi:10.1007/s00262-004-0548-2
   PubMed Web of Science ®Google Scholar
• Dudek AM, Martin S, Garg AD, Agostinis P (2013). Immature, semi-mature, and fully mature dendritic cells: toward A Dc-cancer cells interface that augments anticancer immunity. Front Immunol. 4:438. doi:10.3389/fimmu.2013.00438
   PubMed Web of Science ®Google Scholar
• Foell D, Wittkowski H, Vogl T, Roth J (2007). S100 proteins expressed in phagocytes: a novel group of damage-associated molecular pattern molecules. J Leukoc Biol. 81:28–37. doi:10.1189/jlb.0306170
   PubMed Web of Science ®Google Scholar
• Gajewski TF, Schreiber H, Fu YX (2013). Innate and adaptive immune cells in the tumor microenvironment. Nat Immunol. 14:1014–1022. doi:10.1038/ni.2703
   PubMed Web of Science ®Google Scholar
• Greenson JK, Huang SC, Herron C, Moreno V, Bonner JD, Tomsho LP, Ben-Izhak O, Cohen HI, Trougouboff P, Bejhar J, Sova Y, Pinchev M, Rennert G, Gruber SB (2009). Pathologic predictors of microsatellite instability in colorectal cancer. Am J Surg Pathol. 33:126–133. doi:10.1097/PAS.0b013e31817ec2b1
   PubMed Web of Science ®Google Scholar
• Grivennikov SI, Greten FR, Karin M (2010). Immunity, inflammation, and cancer. Cell. 140:883–899. doi:10.1016/j.cell.2010.01.025
   PubMed Web of Science ®Google Scholar
• Gulubova MV, Ananiev JR, Vlaykova TI, Yovchev Y, Tsoneva V, Manolova IM (2012). Role of dendritic cells in progression and clinical outcome of colon cancer. Int J Colorectal Dis. 27:159–169. doi:10.1007/s00384-011-1334-1
   PubMed Web of Science ®Google Scholar
• Hanahan D, Weinberg RA (2011). Hallmarks of cancer: the next generation. Cell. 144:646–674. doi:10.1016/j.cell.2011.02.013
   PubMed Web of Science ®Google Scholar
• Harbour R, Miller J (2001). A new system for grading recommendations in evidence based guidelines. BMJ. 323:334–6. Retrieved from http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid = 1120936&tool = pmcentrez&rendertype = abstract
   PubMed Web of Science ®Google Scholar
• Iwamoto M, Shinohara H, Miyamoto A, Okuzawa M, Mabuchi H, Nohara T, Gon G, Toyoda M, Tanigawa N (2003). Prognostic value of tumor-infiltrating dendritic cells expressing CD83 in human breast carcinomas. Int J Cancer. 104:92–97. doi:10.1002/ijc.10915
   PubMed Web of Science ®Google Scholar
• Karin M (2006). Nuclear factor-kappaB in cancer development and progression. Nature. 441:431–436. doi:10.1038/nature04870
   PubMed Web of Science ®Google Scholar
• Karthaus N, Torensma R Tel J (2012). Deciphering the message broadcast by tumor-infiltrating dendritic cells. Am J Pathol. 181:733–742. doi:10.1016/j.ajpath.2012.05.012
   PubMed Web of Science ®Google Scholar
• Klintrup K, Mäkinen JM, Kauppila S, Väre PO, Melkko J, Tuominen H, Tuppurainen K, Mäkelä J, Karttunen TJ, Mäkinen MJ (2005). Inflammation and prognosis in colorectal cancer. Eur J Cancer. 41:2645–2654. doi:10.1016/j.ejca.2005.07.017
   PubMed Web of Science ®Google Scholar
• Lee GH, Askari A, Malietzis G, Bernardo D, Clark SK, Knight SC, Al-Hassi HO (2014). The role of CD40 expression in dendritic cells in cancer biology; a systematic review. Curr Cancer Drug Targets. 14:610–620. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/25163469
   PubMed Web of Science ®Google Scholar
• Liska V, Vycital O, Daum O, Novak P, Treska V, Bruha J, Pitule P, Holubec L (2012). Infiltration of colorectal carcinoma by S100 + dendritic cells and CD57 + lymphocytes as independent prognostic factors after radical surgical treatment. Anticancer Res. 32:2129–2132. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/22593500
   PubMed Web of Science ®Google Scholar
• Macián F, Im SH, García-Cózar FJ, Rao A (2004). T-cell anergy. Curr Opin Immunol. 16:209–216. doi:10.1016/j.coi.2004.01.013
   PubMed Web of Science ®Google Scholar
• Malietzis G, Giacometti M, Askari A, Nachiappan S, Kennedy RH, Faiz OD, Aziz O, Jenkins JT (2014). A preoperative neutrophil to lymphocyte ratio of 3 predicts disease-free survival after curative elective colorectal cancer surgery. Ann Surg. 260:287–292. doi:10.1097/SLA.0000000000000216
   PubMed Web of Science ®Google Scholar
• Malietzis G, Johns N, Al-Hassi HO, Knight SC, Kennedy RH, Fearon KCH, Aziz O, Jenkins JT (2015). Low muscularity and myosteatosis is related to the host systemic inflammatory response in patients undergoing surgery for colorectal cancer. Ann Surg. doi:10.1097/SLA.0000000000001113
   Google Scholar
• Mantovani A, Allavena P, Sica A, Balkwill F (2008). Cancer-related inflammation. Nature. 454:436–444. doi:10.1038/nature07205
   PubMed Web of Science ®Google Scholar
• McMillan DC (2008). An inflammation-based prognostic score and its role in the nutrition-based management of patients with cancer. Proc Nutr Soc. 67:257–262. doi:10.1017/S0029665108007131
   PubMed Web of Science ®Google Scholar
• Moher D, Liberati A, Tetzlaff J, Altman DG (2009). Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 6:e1000097. doi:10.1371/journal.pmed.1000097
   PubMed Web of Science ®Google Scholar
• Nagorsen D, Voigt S, Berg E, Stein H, Thiel E, Loddenkemper C (2007). Tumor-infiltrating macrophages and dendritic cells in human colorectal cancer: relation to local regulatory T cells, systemic T-cell response against tumor-associated antigens and survival. J Transl Med. 5:62. doi:10.1186/1479-5876-5-62
   PubMed Web of Science ®Google Scholar
• Naito Y, Saito K, Shiiba K, Ohuchi A, Saigenji K, Nagura H, Ohtani H (1998). CD8 + T cells infiltrated within cancer cell nests as a prognostic factor in human colorectal cancer. Cancer Res, 58:3491–3494. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/9721846
   PubMed Web of Science ®Google Scholar
• Nakayama Y, Inoue Y, Minagawa N, Katsuki T, Nagashima N, Onitsuka K, Tsurudome Y, Sako T, Hirata K, Nagata N, Itoh H (2003). Relationships between S-100 protein-positive cells and clinicopathological factors in patients with colorectal cancer. Anticancer Res. 23:4423–4426. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/14666729
   PubMed Web of Science ®Google Scholar
• Roxburgh CSD, Salmond JM, Horgan PG, Oien K A, McMillan DC (2009). Comparison of the prognostic value of inflammation-based pathologic and biochemical criteria in patients undergoing potentially curative resection for colorectal cancer. Ann Surg. 249:788–793. doi:10.1097/SLA.0b013e3181a3e738
   PubMed Web of Science ®Google Scholar
• Sandel MH, Dadabayev AR, Menon AG, Morreau H, Melief CJM (2005). Prognostic value of tumor-infiltrating dendritic cells in colorectal cancer: role of maturation status and intratumoral localization. Clin Cancer Res. 11: 2576–2582.
   PubMed Web of Science ®Google Scholar
• Schwaab T, Weiss JE, Schned AR, Barth RJ (2001). Dendritic cell infiltration in colon cancer. J Immunother. 24:130–137. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/11265770
   Web of Science ®Google Scholar
• Siegel R, Desantis C, Jemal A (2014). Colorectal cancer statistics, 2014. CA Cancer J Clin. 64:104–117. doi:10.3322/caac.21220
   PubMed Web of Science ®Google Scholar
• Ueno H, Schmitt N, Klechevsky E, Pedroza-Gonzalez A, Matsui T, Zurawski G, Oh S, Fay J, Pascual V, Banchereau J, Palucka K (2010). Harnessing human dendritic cell subsets for medicine. Immunol Rev. 234:199–212. doi:10.1111/j.0105-2896.2009.00884.x
   PubMed Web of Science ®Google Scholar
• Valladeau J, Saeland S (2005). Cutaneous dendritic cells. Semin Immunol. 17:273–283. doi:10.1016/j.smim.2005.05.009
   PubMed Web of Science ®Google Scholar
• Väyrynen JP, Tuomisto A, Klintrup K, Mäkelä J, Karttunen TJ, Mäkinen MJ (2013). Detailed analysis of inflammatory cell infiltration in colorectal cancer. Br J Cancer. 109:1839–1847. doi:10.1038/bjc.2013.508
   PubMed Web of Science ®Google Scholar